In cancer patients, β2-M acts as an enemy in humans and as an oncogenic factor that stimulates the growth and progression of cancers24–26, in particular, β2-M acts directly on tumor cells to increase their growth, survival, and invasiveness by inducing epithelial-to-mesenchymal transition26. This evidence concerns the gene B2M and neoplasm.